levofloxacin has been researched along with Chronic Bronchitis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasi, F; Centanni, S; Del Vecchio, A; Dionisio, P; Rosignoli, MT; Schaberg, T | 1 |
| Kuti, JL; Nicolau, DP | 1 |
| Dubrovskaia, NV; Dvoretskiĭ, LI; Filimonova, OIu; Grudinina, SA; Iakovlev, SV; Sidorenko, SV | 1 |
| Cao, GY; Huang, JA; Liu, YB; Shi, YG; Si, B; Sun, SH; Wu, XJ; Xia, QM; Xiao, ZK; Xu, JF; Zhang, J; Zhang, YY | 1 |
| Bai, C; Huang, W; Mei, C; Wang, J; Xiao, Y; Xiu, Q; Xu, N; Zheng, Q | 1 |
| Baughman, RP; Nicolau, DP; Sutherland, C; Winget, D | 1 |
| Weiss, LR | 1 |
| Iakovlev, SV; Iakovlev, VP | 1 |
| Amsden, GW; Baird, IM; Simon, S; Treadway, G | 1 |
| Ambruzs, ME; Fisher, AC; Grossman, RF; Martinez, FJ; Tennenberg, AM; Walker, K; Zadeikis, N | 1 |
| Amábile-Cuevas, CF; Ariza, H; Caballero, A; García-Calderón, A; Hernández-Oliva, G; Jardim, JR; Urueta-Robledo, J; Vivar-Orozco, R | 1 |
| Cantón, R; Graninger, W; Lode, H; Milkovich, G | 1 |
| Choné, C; Petitpretz, P; Trémolières, F | 1 |
| Conte, JE; Golden, JA; Little, E; McIver, M; Zurlinden, E | 1 |
| Norrby, SR | 1 |
| Burley, CJ; Masterton, RG | 1 |
3 review(s) available for levofloxacin and Chronic Bronchitis
| Article | Year |
|---|---|
[Levofloxacin in the treatment of respiratory infections].
Topics: Acute Disease; Anti-Infective Agents; Bronchitis, Chronic; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Sinusitis | 2002 |
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Community-Acquired Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Factors | 2006 |
Optimal treatment strategies for acute exacerbations of chronic bronchitis: high-risk patients.
Topics: Anti-Infective Agents; Bronchitis, Chronic; Diagnosis, Differential; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Risk Factors | 2001 |
10 trial(s) available for levofloxacin and Chronic Bronchitis
| Article | Year |
|---|---|
Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Dioxolanes; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Forced Expiratory Volume; Humans; Levofloxacin; Male; Middle Aged; Piperazines; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; China; Community-Acquired Infections; Creatinine; Drug Administration Schedule; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal; Prospective Studies; Recurrence | 2009 |
A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Demography; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis | 2010 |
Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Leukocyte Count; Levofloxacin; Macrophages, Alveolar; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Urea; Young Adult | 2012 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2002 |
Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Double-Blind Method; Female; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ofloxacin | 2003 |
Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis, Chronic; Chronic Disease; Cost-Benefit Analysis; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nausea; Ofloxacin; Patient Selection; Streptococcus pneumoniae; Treatment Outcome | 2005 |
Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Aza Compounds; Brazil; Bronchitis, Chronic; Colombia; Double-Blind Method; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Mexico; Middle Aged; Moxifloxacin; Ofloxacin; Peru; Prospective Studies; Quinolines; Treatment Outcome | 2006 |
Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Topics: Aged; Bronchitis, Chronic; Cefuroxime; Female; Heart Failure; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Treatment Outcome | 2007 |
Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis, Chronic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome | 2001 |
3 other study(ies) available for levofloxacin and Chronic Bronchitis
| Article | Year |
|---|---|
Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Female; Humans; Levofloxacin; Lung; Male; Middle Aged; Models, Statistical; Plasma; Retrospective Studies | 2015 |
[Levofloxacin and macrolides in chronic bronchitis exacerbation: comparative analysis of the treatment efficacy and nonrelapsing periods].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bronchitis, Chronic; Clarithromycin; Female; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult | 2007 |
Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Topics: Adult; Aged; Area Under Curve; Blood Chemical Analysis; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chlamydophila pneumoniae; Chromatography, High Pressure Liquid; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Mass Spectrometry; Microbial Sensitivity Tests; Middle Aged; Mycoplasma pneumoniae; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Streptococcus pneumoniae; Time Factors | 2007 |